posted on 2021-11-05, 19:45authored byArmi Tiihonen, Sarah J. Cox-Vazquez, Qiaohao Liang, Mohamed Ragab, Zekun Ren, Noor Titan Putri Hartono, Zhe Liu, Shijing Sun, Cheng Zhou, Nathan C. Incandela, Jakkarin Limwongyut, Alex S. Moreland, Senthilnath Jayavelu, Guillermo C. Bazan, Tonio Buonassisi
New antibiotics are needed to battle
growing antibiotic resistance,
but the development process from hit, to lead, and ultimately to a
useful drug takes decades. Although progress in molecular property
prediction using machine-learning methods has opened up new pathways
for aiding the antibiotics development process, many existing solutions
rely on large data sets and finding structural similarities to existing
antibiotics. Challenges remain in modeling unconventional antibiotic
classes that are drawing increasing research attention. In response,
we developed an antimicrobial activity prediction model for conjugated
oligoelectrolyte molecules, a new class of antibiotics that lacks
extensive prior structure–activity relationship studies. Our
approach enables us to predict the minimum inhibitory concentration
for E. coli K12, with 21 molecular descriptors selected
by recursive elimination from a set of 5305 descriptors. This predictive
model achieves an R2 of 0.65 with no prior
knowledge of the underlying mechanism. We find the molecular representation
optimum for the domain is the key to good predictions of antimicrobial
activity. In the case of conjugated oligoelectrolytes, a representation
reflecting the three-dimensional shape of the molecules is most critical.
Although it is demonstrated with a specific example of conjugated
oligoelectrolytes, our proposed approach for creating the predictive
model can be readily adapted to other novel antibiotic candidate domains.